Cargando…

COVID-19, rheumatic diseases and immune dysregulation—a perspective

The COVID-19 pandemic has resulted in widespread hospitalisations and deaths around the world. As patients with rheumatic diseases generally have increased risk of infections and complications, understandably, there is significant concern of the impact of SARS-CoV-2 on these patients. However, there...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tariq, Shahna, Van Eeden, Charmaine, Tervaert, Jan Willem Cohen, Osman, Mohammed S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Perspectives in Rheumatology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788381/ https://www.ncbi.nlm.nih.gov/pubmed/33411143 http://dx.doi.org/10.1007/s10067-020-05529-y

Ejemplares similares

Fatal COVID-19 infections: Is NK cell dysfunction a link with autoimmune HLH?
por: Osman, Mohammed S., et al.
Publicado: (2020)

Natural Killer Cell Dysfunction and Its Role in COVID-19
por: van Eeden, Charmaine, et al.
Publicado: (2020)

Interplay of diabetes mellitus and rheumatic diseases amidst the COVID-19 pandemic: influence on the risk of infection, outcomes, and immune responses
por: Mehta, Pankti, et al.
Publicado: (2022)

Different systemic rheumatic diseases as risk factors for COVID-19-related mortality
por: Fragoulis, George E., et al.
Publicado: (2022)

Challenges of caring for homeless patients with rheumatic and musculoskeletal disorders in Los Angeles
por: Seto, Richard, et al.
Publicado: (2020)

Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets
por: Misra, Durga Prasanna, et al.
Publicado: (2020)

Do COVID-19 Infections Result in a Different Form of Secondary Hemophagocytic Lymphohistiocytosis
por: Chu, Raymond, et al.
Publicado: (2021)

Patient and parent perspectives on transition from paediatric to adult healthcare in rheumatic diseases: an interview study
por: Jiang, Ivy, et al.
Publicado: (2021)

Are antiphospholipid antibodies just a common epiphenomenon or are they causative of immune-mediated coagulopathy in COVID-19?
por: Castillo-Martínez, Diana, et al.
Publicado: (2021)

Impact of COVID-19 pandemic social restriction measures on people with rheumatic and musculoskeletal diseases in the UK: a mixed-methods study
por: Smith, Toby O, et al.
Publicado: (2021)

Real-world treatment persistence of golimumab in the management of immune-mediated rheumatic diseases in Europe: a systematic literature review
por: Luttropp, Karin, et al.
Publicado: (2019)

Post-traumatic stress disorder in patients with rheumatic disease during the COVID-19 outbreak: a cross-sectional case–control study in China
por: Wu, Xin, et al.
Publicado: (2022)

Impact of Rheumatic Diseases on Oral Health-Related Quality of Life
por: Aloyouny, Ashwag Y, et al.
Publicado: (2022)

Rheumatology and psychiatry: allies in times of COVID-19
por: Elera-Fitzcarrald, Claudia, et al.
Publicado: (2021)

Characteristics of Late-Onset Spondyloarthritis: Data from the Moroccan Registry of Biological Therapies in Rheumatic Diseases
por: Mougui, Ahmed, et al.
Publicado: (2023)

Challenges in delivering rheumatology care during COVID-19 pandemic
por: Nune, A., et al.
Publicado: (2020)

Hydroxychloroquine and chloroquine in COVID-19: should they be used as standard therapy?
por: Ibáñez, Sebastián, et al.
Publicado: (2020)

Moving towards online rheumatology education in the era of COVID-19
por: Ahmed, Sakir, et al.
Publicado: (2020)

Patients’ experiences regarding self-monitoring of the disease course: an observational pilot study in patients with inflammatory rheumatic diseases at a rheumatology outpatient clinic in The Netherlands
por: Renskers, Lisanne, et al.
Publicado: (2020)

Inequity and vulnerability in Latin American Indigenous and non-Indigenous populations with rheumatic diseases: a syndemic approach
por: Granados, Ysabel, et al.
Publicado: (2023)

Hydroxychloroquine in the post-COVID-19 era: will this pandemic upset decades of clinical practice?
por: Pothen, Lucie, et al.
Publicado: (2021)

Impact of COVID-19 on rheumatology practice in the UK—a pan-regional rheumatology survey
por: Nune, Arvind, et al.
Publicado: (2021)

Identification of new biomarkers to promote personalised treatment of patients with inflammatory rheumatic disease: protocol for an open cohort study
por: Kringelbach, Tina Marie, et al.
Publicado: (2018)

Psychometric evaluation of the Arthritis Self-Efficacy Scale in Chinese adults with rheumatic diseases: a cross-sectional study
por: Tsai, Tzung-Yi, et al.
Publicado: (2021)

NET-RMDs study: networks of fatigue and pain in rheumatic and musculoskeletal diseases – protocol for an international cross-sectional study
por: Gavilán-Carrera, Blanca, et al.
Publicado: (2022)

Taking care of systemic sclerosis patients during COVID-19 pandemic: rethink the clinical activity
por: Minniti, Antonina, et al.
Publicado: (2020)

Systemic lupus erythematosus in the light of the COVID-19 pandemic: infection, vaccination, and impact on disease management
por: Mehta, Pankti, et al.
Publicado: (2022)

Challenges, collaboration, and innovation in rheumatology education during the COVID-19 pandemic: leveraging new ways to teach
por: Dua, Anisha B, et al.
Publicado: (2020)

Use of prescription opioids among patients with rheumatic diseases compared to patients with hypertension in the USA: a retrospective cohort study
por: Chen, Sarah K, et al.
Publicado: (2019)

Hand-related physical function in rheumatic hand conditions: a protocol for developing a patient-reported outcome measurement instrument
por: Klokker, Louise, et al.
Publicado: (2016)

Are patients with rheumatologic diseases on chronic immunosuppressive therapy at lower risk of developing severe symptoms when infected with COVID-19?
por: Vakil-Gilani, Kiana, et al.
Publicado: (2020)

Discontinuation, persistence and adherence to subcutaneous biologics delivered via a homecare route to Scottish adults with rheumatic diseases: a retrospective study
por: Alvarez-Madrazo, Samantha, et al.
Publicado: (2019)

Comparative effectiveness of first-line biological monotherapy use in rheumatoid arthritis: a retrospective analysis of the RECord-linkage On Rheumatic Diseases study on health care administrative databases
por: Silvagni, Ettore, et al.
Publicado: (2018)

Value of pulmonary artery pressure in predicting in-hospital and one-year mortality after valve replacement surgery in middle-aged and aged patients with rheumatic mitral disease: an observational study
por: Jiang, Lei, et al.
Publicado: (2017)

Evidence of a Novel Mitochondrial Signature in Systemic Sclerosis Patients with Chronic Fatigue Syndrome
por: van Eeden, Charmaine, et al.
Publicado: (2023)

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and fibromyalgia: PR3-versus MPO-ANCA-associated vasculitis, an exploratory cross-sectional study
por: van Eeden, Charmaine, et al.
Publicado: (2023)

Vaccine hesitancy is not increased in patients with ASIA (autoimmune/inflammatory syndrome induced by adjuvants) when compared to patients with vasculitis
por: Cohen Tervaert, Jan Willem, et al.
Publicado: (2023)

Autoimmune post-COVID vaccine syndromes: does the spectrum of autoimmune/inflammatory syndrome expand?
por: Jara, Luis J., et al.
Publicado: (2022)

Can the adherence to quality of care indicators for early rheumatoid arthritis in clinical practice reduce risk of hospitalisation? Retrospective cohort study based on the Record Linkage of Rheumatic Disease study of the Italian Society for Rheumatology
por: Zanetti, Anna, et al.
Publicado: (2020)

Protocol for a multicentre randomised controlled parallel-group trial to compare the effectiveness of remotely delivered cognitive-behavioural and graded exercise interventions with usual care alone to lessen the impact of fatigue in inflammatory rheumatic diseases (LIFT)
por: Martin, Kathryn R, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_n8j81p5naun7h33ur4o7fj0r4o